FDA Adverse Event Injury Summary report: N

BILIARY STENT, BILIARY STENT SYSTEM, BILIARY ENDOPROSTHESIS

MDR report key: 1994037 · Received February 16, 2011

Report

Report Number
3005099803-2011-00302
Event Type
Injury
Date Received
February 16, 2011
Date of Event
January 14, 2011
Report Date
January 24, 2011
Manufacturer
BOSTON SCIENTIFIC - MARLBOROUGH
Product Code
FGE
PMA / PMN Number
K965147
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
LA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4), NO CODE AVAILABLE (THERAPY/NON-SURGICAL TREATMENT, ADDITIONAL). THE COMPLAINANT INDICATED THAT THE DEVICE HAS BEEN DISPOSED; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 1

NOTE: THIS REPORT PERTAINS TO ONE OF FOUR DEVICES USED DURING THE SAME PROCEDURE. MANUFACTURER REPORT # 3005099803-2011-00301, 3005099803-2011-00303, AND 3005099803-2011-00304 ADDRESS THESE DEVICES. IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT FOUR 7FR X 5CM FLEXIMA BILIARY STENT SYSTEMS WERE USED DURING AN ERCP (ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY) PROCEDURE IN THE COMMON BILE DUCT OF (B)(6) FEMALE PATIENT (PATIENT WEIGHT IS UNKNOWN). DURING THE PROCEDURE, THE FOUR 7FR X 5CM FLEXIMA BILIARY STENT SYSTEM GUIDE CATHETER BROKE INTO MULTIPLE PIECES AS THEY WERE RETRACTED FOR STENT DEPLOYMENT. THE DEVICES WERE REMOVED FROM THE PATIENT AND ALL GUIDE CATHETER PIECES AND STENTS WERE REMOVED WITH FORCEPS. THE PROCEDURE WAS COMPLETED WITH A 7FR X 7CM FLEXIMA BILIARY STENT SYSTEM WITH NO REPORTED PATIENT COMPLICATIONS. THE PATIENT WAS REPORTED TO BE FINE AFTER THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 BILIARY STENT, BILIARY STENT SYSTEM, BILIARY ENDOPROSTHESIS CATHETER, BILIARY, DIAGNOSTIC FGE BOSTON SCIENTIFIC - MARLBOROUGH M00539200 13977672

Patients

Seq Age Sex Outcome Treatment
1 82 YR Required Intervention